<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T21:52:11Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/8750" metadataPrefix="oai_dc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/8750</identifier><datestamp>2024-03-05T01:05:13Z</datestamp><setSpec>com_10259_4219</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4220</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations</dc:title>
<dc:creator>Kroonenberg, Pieter M.</dc:creator>
<dc:creator>Oort, Frans J.</dc:creator>
<dc:creator>Stebbins, Glenn T.</dc:creator>
<dc:creator>Leurgans, Sue E.</dc:creator>
<dc:creator>Cubo Delgado, Esther</dc:creator>
<dc:creator>Goetz, Christopher G.</dc:creator>
<dc:subject>Baseline Model</dc:subject>
<dc:subject>Progressive Supranuclear Palsy</dc:subject>
<dc:subject>Residual Covariance</dc:subject>
<dc:subject>Progressive Supranuclear Palsy Patient</dc:subject>
<dc:subject>Salud</dc:subject>
<dc:subject>Medicina</dc:subject>
<dc:subject>Health</dc:subject>
<dc:subject>Medicine</dc:subject>
<dc:description>In order to better understand the similarities and differences in the motor behaviour of different groups of patients, their scores on the Motor Examination section of the Unified Parkinson's Disease Rating Scale (UPDRS) were analysed simultaneously. The three groups consisted, respectively, of patients with Parkinson's disease (PD) on medication, patients with Parkinson's disease withdrawn from anti-parkinsonian medication for at least 12 hours, and patients diagnosed with a specific Parkinsonism syndrome: Progressive Supranuclear Palsy (PSP).</dc:description>
<dc:description>This research was supported by the Parkinson's Disease Foundation. The first two authors (PMK, FJO) were partially supported by a grant from the Netherlands Organisation of Scientific Research (NWO grant 575-30-005).</dc:description>
<dc:date>2024-03-04T13:15:11Z</dc:date>
<dc:date>2024-03-04T13:15:11Z</dc:date>
<dc:date>2006-06</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>http://hdl.handle.net/10259/8750</dc:identifier>
<dc:identifier>10.1186/1471-2288-6-26</dc:identifier>
<dc:identifier>1471-2288</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>BMC Medical Research Methodology. 2006, V. 6, n. 1</dc:relation>
<dc:relation>https://doi.org/10.1186/1471-2288-6-26</dc:relation>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Springer Nature</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>